Post-stroke Epilepsy: Primary Prophylaxis Study

NCT04858841 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

180

Enrollment

OTHER

Sponsor class

Conditions

Middle Cerebral Artery Stroke

Interventions

DRUG: Levetiracetam Oral Product
DRUG: Perampanel Oral Product
DRUG: Placebo

Sponsor

National Cheng Kung University

Collaborators

[object Object]
[object Object]